These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7572724)

  • 41. Immunoglobulin E-suppressing and immunoglobulin G-enhancing tetanus toxoid prepared by conjugation with pullulan.
    Mitani S; Yamamoto A; Ikegami H; Usui M; Matuhasi T
    Infect Immun; 1982 Jun; 36(3):971-6. PubMed ID: 7095857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
    Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
    Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.
    Lue C; van den Wall Bake AW; Prince SJ; Julian BA; Tseng ML; Radl J; Elson CO; Mestecky J
    Clin Exp Immunol; 1994 May; 96(2):356-63. PubMed ID: 8187345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic response to early and routine DTP immunization in infants.
    Baraff LJ; Leake RD; Burstyn DG; Payne T; Cody CL; Manclark CR; St Geme JW
    Pediatrics; 1984 Jan; 73(1):37-42. PubMed ID: 6318185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.
    Ma Y; Ross AC
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13556-61. PubMed ID: 16157890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres.
    Sajadi Tabassi SA; Tafaghodi M; Jaafari MR
    Int J Pharm; 2008 Aug; 360(1-2):12-7. PubMed ID: 18538516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
    Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
    Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The humoral immune response after thermal injury: an experimental model.
    Molloy RG; Nestor M; Collins KH; Holzheimer RG; Mannick JA; Rodrick ML
    Surgery; 1994 Mar; 115(3):341-8. PubMed ID: 8128358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of skeletal unloading on the antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice.
    Rettig TA; Bye BA; Nishiyama NC; Hlavacek S; Ward C; Pecaut MJ; Chapes SK
    PLoS One; 2019; 14(1):e0210284. PubMed ID: 30653556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A promising model of primary human immunization in human-scid mouse.
    Bombil F; Kints JP; Scheiff JM; Bazin H; Latinne D
    Immunobiology; 1996 Aug; 195(3):360-75. PubMed ID: 8877409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and in vivo study of dry powder microspheres for nasal immunization.
    Tafaghodi M; Rastegar S
    J Drug Target; 2010 Apr; 18(3):235-42. PubMed ID: 19929307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of tetanus toxoid powder needleless injection on the concentration of serum antibody IgG in mice].
    Wang JB; Zhou X; Wang ZW; Jin C; Xiao XH
    Yao Xue Xue Bao; 2009 Dec; 44(12):1406-9. PubMed ID: 21351478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization.
    Waldo FB
    J Clin Lab Immunol; 1991 Mar; 34(3):125-9. PubMed ID: 1667944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.
    Stevens RH; Saxon A
    Cell Immunol; 1979 Jun; 45(1):142-50. PubMed ID: 455480
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.